View in EDS

Neoantigen-specific CD4+ tumor-infiltrating lymphocytes are potent effectors identified within adoptive cell therapy products for metastatic melanoma patients.

Saved in:
Bibliographic Details
Title: Neoantigen-specific CD4+ tumor-infiltrating lymphocytes are potent effectors identified within adoptive cell therapy products for metastatic melanoma patients.
Authors: Hall MS; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.; Cancer Biology PhD Program, University of South Florida, Tampa, Florida, USA., Teer JK; Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Yu X; Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Branthoover H; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Snedal S; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Rodriguez-Valentin M; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Nagle L; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Scott E; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Schachner B; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Innamarato P; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Hall AM; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Blauvelt J; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Rich CJ; Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Richards AD; Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Ceccarelli J; Turnstone Biologics, Inc, San Diego, California, USA., Langer TJ; Turnstone Biologics, Inc, San Diego, California, USA., Yoder SJ; Molecular Genomics Core, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Beatty MS; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Cox CA; Cell Therapies Core Facility, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Messina JL; Department of Anatomic Pathology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Abate-Daga D; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Mule JJ; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Mullinax JE; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.; Department of Sarcoma, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Sarnaik AA; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.; Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Pilon-Thomas S; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA shari.pilon-thomas@moffitt.org.
Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2023 Oct; Vol. 11 (10).
Publication Type: Journal Article; Research Support, N.I.H., Extramural
Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37802604
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Neoantigen-specific CD4<superscript>+</superscript> tumor-infiltrating lymphocytes are potent effectors identified within adoptive cell therapy products for metastatic melanoma patients.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Hall+MS%22">Hall MS</searchLink>; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.; Cancer Biology PhD Program, University of South Florida, Tampa, Florida, USA.<br /><searchLink fieldCode="AU" term="%22Teer+JK%22">Teer JK</searchLink>; Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.<br /><searchLink fieldCode="AU" term="%22Yu+X%22">Yu X</searchLink>; Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.<br /><searchLink fieldCode="AU" term="%22Branthoover+H%22">Branthoover H</searchLink>; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.<br /><searchLink fieldCode="AU" term="%22Snedal+S%22">Snedal S</searchLink>; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.<br /><searchLink fieldCode="AU" term="%22Rodriguez-Valentin+M%22">Rodriguez-Valentin M</searchLink>; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.<br /><searchLink fieldCode="AU" term="%22Nagle+L%22">Nagle L</searchLink>; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.<br /><searchLink fieldCode="AU" term="%22Scott+E%22">Scott E</searchLink>; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.<br /><searchLink fieldCode="AU" term="%22Schachner+B%22">Schachner B</searchLink>; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.<br /><searchLink fieldCode="AU" term="%22Innamarato+P%22">Innamarato P</searchLink>; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.<br /><searchLink fieldCode="AU" term="%22Hall+AM%22">Hall AM</searchLink>; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.<br /><searchLink fieldCode="AU" term="%22Blauvelt+J%22">Blauvelt J</searchLink>; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.<br /><searchLink fieldCode="AU" term="%22Rich+CJ%22">Rich CJ</searchLink>; Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.<br /><searchLink fieldCode="AU" term="%22Richards+AD%22">Richards AD</searchLink>; Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.<br /><searchLink fieldCode="AU" term="%22Ceccarelli+J%22">Ceccarelli J</searchLink>; Turnstone Biologics, Inc, San Diego, California, USA.<br /><searchLink fieldCode="AU" term="%22Langer+TJ%22">Langer TJ</searchLink>; Turnstone Biologics, Inc, San Diego, California, USA.<br /><searchLink fieldCode="AU" term="%22Yoder+SJ%22">Yoder SJ</searchLink>; Molecular Genomics Core, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.<br /><searchLink fieldCode="AU" term="%22Beatty+MS%22">Beatty MS</searchLink>; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.<br /><searchLink fieldCode="AU" term="%22Cox+CA%22">Cox CA</searchLink>; Cell Therapies Core Facility, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.<br /><searchLink fieldCode="AU" term="%22Messina+JL%22">Messina JL</searchLink>; Department of Anatomic Pathology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.<br /><searchLink fieldCode="AU" term="%22Abate-Daga+D%22">Abate-Daga D</searchLink>; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.<br /><searchLink fieldCode="AU" term="%22Mule+JJ%22">Mule JJ</searchLink>; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.<br /><searchLink fieldCode="AU" term="%22Mullinax+JE%22">Mullinax JE</searchLink>; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.; Department of Sarcoma, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.<br /><searchLink fieldCode="AU" term="%22Sarnaik+AA%22">Sarnaik AA</searchLink>; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.; Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.<br /><searchLink fieldCode="AU" term="%22Pilon-Thomas+S%22">Pilon-Thomas S</searchLink>; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA shari.pilon-thomas@moffitt.org.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101620585%22">Journal for immunotherapy of cancer</searchLink> [J Immunother Cancer] 2023 Oct; Vol. 11 (10).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BMJ+Publishing+Group+Ltd%22">BMJ Publishing Group Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101620585 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2051-1426 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220511426%22">20511426 </searchLink><i>NLM ISO Abbreviation: </i>J Immunother Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37802604
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1136/jitc-2023-007288
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Neoantigen-specific CD4+ tumor-infiltrating lymphocytes are potent effectors identified within adoptive cell therapy products for metastatic melanoma patients.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Hall MS
      – PersonEntity:
          Name:
            NameFull: Teer JK
      – PersonEntity:
          Name:
            NameFull: Yu X
      – PersonEntity:
          Name:
            NameFull: Branthoover H
      – PersonEntity:
          Name:
            NameFull: Snedal S
      – PersonEntity:
          Name:
            NameFull: Rodriguez-Valentin M
      – PersonEntity:
          Name:
            NameFull: Nagle L
      – PersonEntity:
          Name:
            NameFull: Scott E
      – PersonEntity:
          Name:
            NameFull: Schachner B
      – PersonEntity:
          Name:
            NameFull: Innamarato P
      – PersonEntity:
          Name:
            NameFull: Hall AM
      – PersonEntity:
          Name:
            NameFull: Blauvelt J
      – PersonEntity:
          Name:
            NameFull: Rich CJ
      – PersonEntity:
          Name:
            NameFull: Richards AD
      – PersonEntity:
          Name:
            NameFull: Ceccarelli J
      – PersonEntity:
          Name:
            NameFull: Langer TJ
      – PersonEntity:
          Name:
            NameFull: Yoder SJ
      – PersonEntity:
          Name:
            NameFull: Beatty MS
      – PersonEntity:
          Name:
            NameFull: Cox CA
      – PersonEntity:
          Name:
            NameFull: Messina JL
      – PersonEntity:
          Name:
            NameFull: Abate-Daga D
      – PersonEntity:
          Name:
            NameFull: Mule JJ
      – PersonEntity:
          Name:
            NameFull: Mullinax JE
      – PersonEntity:
          Name:
            NameFull: Sarnaik AA
      – PersonEntity:
          Name:
            NameFull: Pilon-Thomas S
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 10
              Text: 2023 Oct
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 2051-1426
          Numbering:
            – Type: volume
              Value: 11
            – Type: issue
              Value: 10
          Titles:
            – TitleFull: Journal for immunotherapy of cancer
              Type: main
ResultId 1